1. Home
  2. FRGE vs ASMB Comparison

FRGE vs ASMB Comparison

Compare FRGE & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forge Global Holdings Inc.

FRGE

Forge Global Holdings Inc.

HOLD

Current Price

$44.57

Market Cap

615.4M

Sector

Technology

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$34.99

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRGE
ASMB
Founded
2014
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
615.4M
553.6M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
FRGE
ASMB
Price
$44.57
$34.99
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$31.00
$43.40
AVG Volume (30 Days)
451.9K
108.4K
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$92,884,000.00
$37,191,000.00
Revenue This Year
$33.10
$42.01
Revenue Next Year
$24.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.40
31.30
52 Week Low
$6.60
$7.75
52 Week High
$44.76
$39.71

Technical Indicators

Market Signals
Indicator
FRGE
ASMB
Relative Strength Index (RSI) 85.45 52.92
Support Level $44.30 $32.25
Resistance Level $44.75 $36.92
Average True Range (ATR) 0.14 1.68
MACD -0.75 -0.47
Stochastic Oscillator 67.27 41.71

Price Performance

Historical Comparison
FRGE
ASMB

About FRGE Forge Global Holdings Inc.

Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: